Results for this period
Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in Millions of yen).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Higher sales driven by the recovery in demand for generative AI-related semiconductors and other products, lower inventory valuation losses recognized in the previous fiscal year, and improved profitability through structural reforms and the selection and concentration of projects contributed to higher income. In the Industrial Process business, however, lower sales, increased upfront investment and temporary valuation losses on stagnant assets and other items reduced income.
No applicable matters (There are no applicable matters.)
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | 179,211 Millions of yen (YoY +0.9%) |
| Operating profit | 11,959 Millions of yen (YoY +35.5%) |
| Ordinary income | 13,346 Millions of yen (YoY +7.2%) |
| Profit attributable to owners of the parent | 7,995 Millions of yen (YoY +17.6%) |
| Net income per share | ¥94.88 |
| Equity ratio | End of the current fiscal period 59.9 / End of previous period 67.4 |
| Total assets | 331,078 Millions of yen |
| Net assets | 198,338 Millions of yen |
| Cash flows from operating activities | 18,144 Millions of yen |
| Cash flows from investing activities | -14,109 Millions of yen |
| Cash flows from financing activities | 4,195 Millions of yen |
| Cash and cash equivalents at end of period | 71,868 Millions of yen |
| Full-year earnings forecast | Net Sales ¥2,100 million (YoY +17.2%) / Operating profit ¥140 million (YoY +17.1%) / Ordinary income ¥140 million (YoY +4.9%) / Net income ¥105 million (YoY +31.3%) |
| Segment revenue | Segment Industrial Process business / Net Sales 77,142 Millions of yen (YoY -2.3%), Segment Visual Imaging business / Net Sales 83,882 Millions of yen (YoY +3.7%), Segment Life Science Business / Net Sales 6,259 Millions of yen (YoY +2.4%), Segment Photonics Solution business / Net Sales 10,585 Millions of yen (YoY +2.7%), Segment Other businesses / Net Sales 1,362 Millions of yen (YoY -1.4%) |
| Segment profit | Segment Industrial Process business / Segment profit 6,486 Millions of yen (YoY -32.6%), Segment Visual Imaging business / Segment profit 4,667 Millions of yen (YoY +539.7%), Segment Life Science Business / Segment profit 140 Millions of yen / Prior-year period Segment loss of ¥1,079 million, Segment Photonics Solution business / Segment profit 564 Millions of yen / Prior-year period Segment loss of ¥415 million, Segment Other businesses / Segment profit 183 Millions of yen (YoY +122.8%) |
| Depreciation and amortization | 8,572 Millions of yen |
| Impairment loss | ¥1,301 million (assets subject to impairment: Not disclosed) |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets 46 Millions of yen, Gain on sale of investment securities 10,091 Millions of yen / Extraordinary loss Loss on Disposal of Fixed Assets 449 Millions of yen, Loss on sale of fixed assets 32 Millions of yen, Impairment Losses 1,301 Millions of yen, Impairment loss on investment securities 159 Millions of yen, Business structure improvement expenses 6,330 Millions of yen |
| Disclosure regarding the going concern assumption | No applicable matters (There are no applicable matters.) |
| Changes in the scope of consolidation | New Number of companies 1 / Company name Not disclosed / Excluded Not disclosed |
| Material subsequent events | No applicable matters. |
| Factors Behind Changes in Business Performance | Higher sales driven by the recovery in demand for generative AI-related semiconductors and other products, lower inventory valuation losses recognized in the previous fiscal year, and improved profitability through structural reforms and the selection and concentration of projects contributed to higher income. In the Industrial Process business, however, lower sales, increased upfront investment and temporary valuation losses on stagnant assets and other items reduced income. |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Sales of certain products increased as demand for personal computers, smartphones and generative AI-related semiconductors recovered. In the Visual Imaging business, lower inventory valuation losses than in the previous fiscal year and improved profitability from structural reforms contributed to higher income. In the Life Science and Photonics Solution businesses, the selection and concentration of projects also contributed to higher income. In the Industrial Process business, however, lower sales, increased upfront investment and the recognition of temporary valuation losses on stagnant assets and other items reduced income.